Global Cord Blood (CORBF) Short Interest Ratio & Short Volume

Short interest is the volume of Global Cord Blood shares that have been sold short but have not yet been covered or closed out. As of May 31st, traders have sold 27,500 shares of CORBF short. 0.02% of Global Cord Blood's shares are currently sold short. Learn More on Global Cord Blood's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Global Cord Blood's floating shares are currently sold short.

0.02% of Global Cord Blood's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Global Cord Blood: LifeMD, Inc. (9.71%), Fulgent Genetics, Inc. (8.21%), Castle Biosciences, Inc. (4.85%), Personalis, Inc. (5.73%), InnovAge Holding Corp. (1.40%), Fortrea Holdings Inc. (14.94%), Enhabit, Inc. (3.12%), Celcuity, Inc. (7.93%), Talkspace, Inc. (3.34%), Auna S.A. (0.63%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

Short selling CORBF is an investing strategy that aims to generate trading profit from Global Cord Blood as its price is falling. CORBF shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Global Cord Blood occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CORBF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORBF, twice per month. The most recent reporting period available is May, 31 2025.